Why Cobalamin Deficiency Also Damages Nerves | AI Learning Guide

Here is the key distinction. Folate and cobalamin both end up blocking thymidylate synthesis, so both cause megaloblastic anemia. But cobalamin has a second coenzyme, adenosylcobalamin, that folate cannot replace. Adenosylcobalamin runs methylmalonyl-CoA mutase. When cobalamin is low, methylmalonyl-CoA builds up and is converted to methylmalonic acid, which is toxic to myelin. That is the neuropathy. There is also the methyl trap: without cobalamin, methionine synthase stalls, 5-methyl-THF accumulates, and the folate pool is stuck in a form thymidylate synthase cannot use. So cobalamin deficiency causes anemia through a functional folate deficiency. And if you give folate alone, the anemia improves but the nerve damage keeps progressing.

0:00 / 0:00

Auto-play

The two cobalamin reactions

Methylcobalamin serves methionine synthase, which converts homocysteine to methionine and regenerates THF from 5-methyl-THF. Adenosylcobalamin serves methylmalonyl-CoA mutase, which converts methylmalonyl-CoA to succinyl-CoA. Folate participates in the first reaction but not the second. That single missing reaction is the origin of the neurological damage.

The methyl trap

When methionine synthase stalls, 5-methyl-THF accumulates and the folate pool is trapped in a form that thymidylate synthase cannot use. Cobalamin deficiency therefore produces megaloblastic anemia through a functional folate deficiency, even when total body folate is adequate.

Shared versus distinguishing features

Folate deficiency

Blocks thymidylate synthesis directly
Produces megaloblastic anemia
Does not affect methylmalonyl-CoA mutase
No neuropathy from the deficiency itself

Cobalamin deficiency

Blocks thymidylate synthesis indirectly via the methyl trap
Produces the same megaloblastic anemia
Also blocks methylmalonyl-CoA mutase
Adds subacute combined degeneration of the spinal cord

Treating cobalamin deficiency with folate alone corrects the anemia but does not restore methylmalonyl-CoA mutase activity, so the neurological damage progresses. The anemia is the shared symptom; the neuropathy is the distinguishing one.